Body Revival has been honoured with World's First Clinically Tested Ayurvedic Medicine in Cancer Support at the Atal Samman Samaroh 2026 for its contribution to alternative medicine in cancer support, recognising its work in the domain of clinically validated Ayurvedic cancer care. The recognition was conferred at a national-level ceremony held at Bharat Mandapam, New Delhi, attended by senior political leaders, public representatives, and distinguished guests.
The award was received by Sarosh Khan, Director, Health Reactive, acknowledging the organisation's efforts in developing Ayurvedic medicine for cancer support through a structured, evidence-oriented approach.
Body Revival was recognised under the category "Top Innovation & Social Contribution in Healthcare", highlighting its integration of traditional Ayurvedic knowledge with modern scientific methods and CTRI-registered clinical research. The initiative reflects a growing emphasis on validation and transparency in the field of alternative and complementary healthcare.
The award was presented by Dr Rajbhushan Choudhary, Minister of State, Ministry of Jal Shakti, Government of India, and Shripad Naik, Minister of State, Ministry of New and Renewable Energy, Government of India. The ceremony was attended by several prominent personalities, including actor Huma Qureshi, Kripanath Mallah, Member of Parliament (Lok Sabha), Satish Poonia, State In-Charge, BJP Haryana and Former State President, BJP Rajasthan, and Vinay Choudhary, National Co-Incharge (Research & Policy), Bharatiya Janata Party.
According to the organisation, the Body Revival Ayurvedic formulation intended for cancer supportive care has undergone clinically validated evaluation involving cancer survivors through a government-recognised organisation. The research was conducted by a multidisciplinary team of senior academicians and oncologists and was carried out in accordance with the guidelines of the Indian Council of Medical Research (ICMR). The study was formally registered with the Clinical Trials Registry of India (CTRI), reiterating the importance of following ethical and scientific norms.
The product is positioned as an adjunct Ayurvedic medication for cancer management, with the objective of helping to reduce treatment-related side effects, promote immune health and improve overall quality of life, while being used in conjunction with standard oncology therapies.
In the field of Ayurvedic cancer care, Body Revival has been referenced by senior oncologist Dr Suresh Advani in professional discussions, with related coverage appearing in national media outlets, including Dainik Bhaskar.
The experts who attended the Atal Samman Samaroh 2026 stressed that the future of alternative medicine in cancer support is in clinical validation, transparency, and ethical practice. Body Revival is one such example of this new and evidence-based approach.
The recognition at a national platform such as Bharat Mandapam reflects India's increasing focus on clinically tested and validated Ayurvedic medicine and is expected to encourage further research and innovation in integrative cancer supportive care.
(Note: This article has been written by the Brand Desk.)